NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

NRBO NeuroBo Pharmaceuticals, Inc.

交易中 12-20 13:24:15 EST

2.36

+0.00

0.00%

最高2.36	最低2.36	成交量0.00
今开2.36	昨收2.36	日振幅0.00%
总市值2,033万	流通市值518.45万	总股本861.60万
成交额3.11万	换手率0.00%	流通股本219.68万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

{"stockData":{"symbol":"NRBO","market":"US","secType":"STK","nameCN":"NeuroBo Pharmaceuticals, Inc.","latestPrice":2.36,"timestamp":1732741200000,"preClose":2.36,"halted":8,"volume":0,"delay":0,"floatShares":2196834,"shares":8616010,"eps":-4.294645,"marketStatus":"交易中","marketStatusCode":2,"change":0,"latestTime":"12-20 13:24:15 EST","open":2.36,"high":2.36,"low":2.36,"amount":31119.886798,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.294645,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1734728400000},"symbolChange":{"newSymbol":"MTVA","executeDate":"2024-11-29"},"adr":0,"listingDate":1470369600000,"adjPreClose":2.36,"volumeRatio":0},"requestUrl":"/m/hq/s/NRBO/tweets","defaultTab":"tweets","newsList":[{"id":"2486385920","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘大幅上涨5.49%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2486385920","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2486385920?lang=zh_cn&edition=full","pubTime":"2024-11-25 22:31","pubTimestamp":1732545063,"startTime":"0","endTime":"0","summary":"北京时间2024年11月25日22时31分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速拉升5.49%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.92%。其相关个股中，Citius Pharmaceuticals, Inc.、Scholar Rock Holding Corporation、Bridgebio Pharma, Inc.涨幅较大，Cognition Therapeutics, Inc.、木薯科学、Citius Pharmaceuticals, Inc.较为活跃，换手率分别为85.52%、51.47%、33.72%，振幅较大的相关个股有Iovance Biotherapeutics, Inc.、Kodiak Sciences Inc、Xbiotech Inc.，振幅分别为104.27%、102.58%、102.34%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223109abddf970&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241125223109abddf970&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","NRBO","OXM","BK4139"],"gpt_icon":0},{"id":"2484927928","title":"Neurobo Pharmaceuticals, Inc.盘中异动 急速拉升5.16%报2.43美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484927928","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484927928?lang=zh_cn&edition=full","pubTime":"2024-11-20 00:37","pubTimestamp":1732034276,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日00时37分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.16%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.81%。其相关个股中，Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Dogwood Therapeutics, Inc.涨幅较大，Tff Pharmaceuticals, Inc.、Syros Pharmaceuticals, Inc.、Exicure, Inc.较为活跃，换手率分别为811.69%、252.58%、122.88%，振幅较大的相关个股有Syros Pharmaceuticals, Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 ，振幅分别为89.34%、81.67%、62.18%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000375698e438df&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024112000375698e438df&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","NRBO","BK4202","OXM"],"gpt_icon":0},{"id":"2484367629","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨7.03%报2.38美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484367629","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484367629?lang=zh_cn&edition=full","pubTime":"2024-11-18 22:34","pubTimestamp":1731940440,"startTime":"0","endTime":"0","summary":"北京时间2024年11月18日22时34分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速上涨7.03%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，Hcw Biologics Inc.、冠科美博、Fate Therapeutics, Inc.涨幅较大，Tharimmune, Inc.、Hcw Biologics Inc.、冠科美博较为活跃，换手率分别为522.84%、225.36%、193.17%，振幅较大的相关个股有Hcw Biologics Inc.、Fate Therapeutics, Inc.、冠科美博，振幅分别为67.89%、41.09%、34.31%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223400a2432ce8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241118223400a2432ce8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","BK4139","OXM","NRBO"],"gpt_icon":0},{"id":"2483880445","title":"Neurobo Pharmaceuticals, Inc.盘中异动 大幅下挫5.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2483880445","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483880445?lang=zh_cn&edition=full","pubTime":"2024-11-16 02:07","pubTimestamp":1731694027,"startTime":"0","endTime":"0","summary":"北京时间2024年11月16日02时07分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅跳水5.44%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为3.62%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116020707a23bc577&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241116020707a23bc577&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","BK4139","OXM","NRBO"],"gpt_icon":0},{"id":"2483571478","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘快速下挫6.64%报2.39美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2483571478","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2483571478?lang=zh_cn&edition=full","pubTime":"2024-11-14 04:46","pubTimestamp":1731530760,"startTime":"0","endTime":"0","summary":"北京时间2024年11月14日04时46分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速跳水6.64%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.、Calidi Biotherapeutics, Inc.涨幅较大，Elevai Labs, Inc.、Cyclacel Pharmaceuticals, Inc.、Calidi Biotherapeutics, Inc.较为活跃，换手率分别为736.20%、572.69%、178.61%，振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Nkgen Biotech Inc C/Wts 31/05/2028、Pulmatrix, Inc.，振幅分别为140.00%、134.66%、86.83%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111404460198e42750&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111404460198e42750&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["PULM","BK4007","OXM","NRBO","BK4202","BK4139"],"gpt_icon":0},{"id":"2482763089","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大涨5.43%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482763089","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482763089?lang=zh_cn&edition=full","pubTime":"2024-11-12 22:53","pubTimestamp":1731423180,"startTime":"0","endTime":"0","summary":"北京时间2024年11月12日22时53分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.43%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.21%。其相关个股中，Geovax Labs Inc C/Wts 29/09/2025、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nls Pharmaceutics Ltd C/Wts 02/02/2026涨幅较大，Geovax Labs, Inc.、Cero Therapeutics Holdings, Inc.、Elevai Labs, Inc.较为活跃，换手率分别为150.41%、142.22%、74.32%，振幅较大的相关个股有Cero Therapeutics Holdings, Inc.、Geovax Labs Inc C/Wts 29/09/2025、Heron Therapeutics, Inc.，振幅分别为49.39%、34.55%、26.63%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222530195be1a31&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024111222530195be1a31&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4139","BK4202","OXM"],"gpt_icon":0},{"id":"2481483621","title":"NeuroBo Pharmaceuticals Inc    预计每股亏损 89 美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2481483621","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481483621?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:49","pubTimestamp":1731080960,"startTime":"0","endTime":"0","summary":"   * 预计NeuroBo Pharmaceuticals Inc    在公布截至2024年12月31日的财报时，季度营收将保持不变。*    * LSEG分析师对NeuroBo Pharmaceuticals Inc的平均预期是每股亏损89美分。* 华尔街对 NeuroBo Pharmaceuticals Inc 的 12 个月目标价中位数为 22.00 美元，高于其最新收盘价 2.68 美元。11月8日 - 上一季度业绩。除非另有说明，否则所有数据均以美元为单位。(如对本报告中的数据有任何疑问，请联系 Estimates.Support@lseg.com。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"NeuroBo Pharmaceuticals Inc    预计每股亏损 89 美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NRBO"],"gpt_icon":0},{"id":"2481102734","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘急速拉升5.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481102734","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481102734?lang=zh_cn&edition=full","pubTime":"2024-11-08 23:02","pubTimestamp":1731078128,"startTime":"0","endTime":"0","summary":"北京时间2024年11月08日23时02分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价大幅上涨5.22%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108230209a224d5e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241108230209a224d5e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4202","OXM","BK4139"],"gpt_icon":0},{"id":"2481298596","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481298596","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481298596?lang=zh_cn&edition=full","pubTime":"2024-11-06 22:41","pubTimestamp":1730904061,"startTime":"0","endTime":"0","summary":"北京时间2024年11月06日22时41分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价大幅拉升5.12%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.04%。其相关个股中，Sonnet Biotherapeutics Holdings, Inc.、Sab Biotherapeutics Inc C/Wts 22/10/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Sonnet Biotherapeutics Holdings, Inc.、Elevai Labs, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为1070.77%、129.77%、61.14%，振幅较大的相关个股有Lakeshore Biopharma Co., Ltd、Uniqure N.V.、Inmed Pharmaceuticals Inc.，振幅分别为109.56%、106.60%、106.04%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224101971a4c8d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241106224101971a4c8d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4202","OXM","BK4139"],"gpt_icon":0},{"id":"2481688244","title":"Neurobo Pharmaceuticals, Inc.盘中异动 大幅拉升7.51%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481688244","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481688244?lang=zh_cn&edition=full","pubTime":"2024-11-05 22:32","pubTimestamp":1730817139,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日22时32分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速拉升7.51%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.08%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522321995bdd208&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110522321995bdd208&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4139","BK4202","OXM"],"gpt_icon":0},{"id":"2480058198","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘大幅下挫6.37%报2.50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480058198","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480058198?lang=zh_cn&edition=full","pubTime":"2024-11-04 22:31","pubTimestamp":1730730670,"startTime":"0","endTime":"0","summary":"北京时间2024年11月04日22时31分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速下挫6.37%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.14%。其相关个股中，Nls Pharmaceutics Ltd.、Disc Medicine, Inc.、Neurogene Inc.涨幅较大，Nls Pharmaceutics Ltd.、Elevai Labs, Inc.、Gri Bio, Inc.较为活跃，换手率分别为228.35%、121.40%、39.38%，振幅较大的相关个股有Allakos Inc.、Neumora Therapeutics, Inc.、Tango Therapeutics, Inc.，振幅分别为3.94%、3.85%、3.40%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422311095bdc98b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110422311095bdc98b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","OXM","NRBO"],"gpt_icon":0},{"id":"2480889186","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘股价大涨5.05%报2.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2480889186","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480889186?lang=zh_cn&edition=full","pubTime":"2024-11-01 21:40","pubTimestamp":1730468449,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日21时40分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速上涨5.05%。截至发稿，该股报2.70美元/股，成交量483股，换手率0.01%，振幅4.95%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.84%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101214049971a3d98&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241101214049971a3d98&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OXM","NRBO","BK4202"],"gpt_icon":0},{"id":"2479752439","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘快速跳水5.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479752439","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479752439?lang=zh_cn&edition=full","pubTime":"2024-10-31 03:45","pubTimestamp":1730317521,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日03时45分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速下跌5.59%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.31%。其相关个股中，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Tharimmune, Inc.、Ensysce Biosciences, Inc.、Gri Bio, Inc.较为活跃，换手率分别为5256.61%、3147.83%、444.53%，振幅较大的相关个股有Tharimmune, Inc.、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 、Ensysce Biosciences, Inc.，振幅分别为151.72%、91.64%、77.90%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103103452298e3f7ca&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024103103452298e3f7ca&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","OXM","NRBO","BK4202"],"gpt_icon":0},{"id":"2479891902","title":"Neurobo Pharmaceuticals, Inc.盘中异动 股价大跌8.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479891902","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479891902?lang=zh_cn&edition=full","pubTime":"2024-10-29 22:21","pubTimestamp":1730211662,"startTime":"0","endTime":"0","summary":"北京时间2024年10月29日22时21分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价大幅下挫8.25%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为0.37%。其相关个股中，Glycomimetics, Inc.、Klotho Neurosciences Inc C/Wts 21/06/2029 、Nkgen Biotech Inc C/Wts 31/05/2028涨幅较大，Lixte Biotechnology Holdings, Inc.、Glycomimetics, Inc.、Novabay Pharmaceuticals, Inc.较为活跃，换手率分别为627.24%、497.29%、297.13%，振幅较大的相关个股有Glycomimetics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Rocket Pharmaceuticals Inc C/Wts 02/09/2026 ，振幅分别为160.88%、88.24%、65.41%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029222102ab7f3fc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241029222102ab7f3fc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4139","BK4202","OXM"],"gpt_icon":0},{"id":"2478860924","title":"Neurobo Pharmaceuticals, Inc.盘中异动 急速上涨7.91%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478860924","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478860924?lang=zh_cn&edition=full","pubTime":"2024-10-28 21:41","pubTimestamp":1730122907,"startTime":"0","endTime":"0","summary":"北京时间2024年10月28日21时41分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价大幅上涨7.91%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.50%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Monte Rosa Therapeutics, Inc.、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Tc Biopharm  Plc、Viracta Therapeutics, Inc.、Immunoprecise Antibodies Ltd.较为活跃，换手率分别为556.76%、49.12%、38.08%，振幅较大的相关个股有Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Monte Rosa Therapeutics, Inc.、Monopar Therapeutics Inc.，振幅分别为45.41%、21.06%、18.55%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214147ab7bc999&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241028214147ab7bc999&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","OXM","BK4139","NRBO"],"gpt_icon":0},{"id":"2478631309","title":"Neurobo Pharmaceuticals, Inc.盘中异动 下午盘股价大涨6.07%报2.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2478631309","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478631309?lang=zh_cn&edition=full","pubTime":"2024-10-26 03:20","pubTimestamp":1729884049,"startTime":"0","endTime":"0","summary":"北京时间2024年10月26日03时20分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价大幅拉升6.07%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.55%。其相关个股中，Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、Iterum Therapeutics Plc、Pasithea Therapeutics Corp C/Wts 12/08/2026 涨幅较大，180 Life Sciences Corp.、Elevai Labs, Inc.、Iterum Therapeutics Plc较为活跃，换手率分别为861.23%、791.08%、417.54%，振幅较大的相关个股有Iterum Therapeutics Plc、Elevai Labs, Inc.、Qualigen Therapeutics, Inc.，振幅分别为102.56%、93.82%、91.58%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026032050971a2635&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241026032050971a2635&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4202","NRBO","OXM","BK4139"],"gpt_icon":0},{"id":"2477329360","title":"Neurobo Pharmaceuticals, Inc.盘中异动 临近收盘急速下跌5.48%报2.76美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477329360","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477329360?lang=zh_cn&edition=full","pubTime":"2024-10-23 03:46","pubTimestamp":1729626375,"startTime":"0","endTime":"0","summary":"北京时间2024年10月23日03时46分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价急速跳水5.48%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.07%。其相关个股中，Ensysce Biosciences, Inc.、Genprex, Inc.、Silexion Therapeutics Corp C/Wts Exp 15/08/2029 涨幅较大，Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm  Plc较为活跃，换手率分别为6842.27%、5239.70%、2214.07%，振幅较大的相关个股有Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.，振幅分别为189.27%、101.99%、99.41%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023034615a1e2dc5c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241023034615a1e2dc5c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["OXM","BK4202","BK4139","NRBO"],"gpt_icon":0},{"id":"2476447294","title":"Neurobo Pharmaceuticals, Inc.盘中异动 急速下挫5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476447294","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476447294?lang=zh_cn&edition=full","pubTime":"2024-10-19 02:32","pubTimestamp":1729276378,"startTime":"0","endTime":"0","summary":"北京时间2024年10月19日02时32分，Neurobo Pharmaceuticals, Inc.股票出现波动，股价快速跳水5.06%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019023258ab6b36fd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241019023258ab6b36fd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["NRBO","BK4139","BK4202","OXM"],"gpt_icon":0},{"id":"2476175819","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘大幅上涨6.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2476175819","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2476175819?lang=zh_cn&edition=full","pubTime":"2024-10-17 22:02","pubTimestamp":1729173754,"startTime":"0","endTime":"0","summary":"北京时间2024年10月17日22时02分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价快速拉升6.42%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体涨幅为0.85%。其相关个股中，Klotho Neurosciences Inc C/Wts 21/06/2029 、Tevogen Bio Holdings Inc.、Molecular Templates, Inc.涨幅较大，Notable Labs, Ltd.、Molecular Templates, Inc.、Zyversa Therapeutics, Inc.较为活跃，换手率分别为330.40%、255.15%、157.23%，振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tevogen Bio Holdings Inc.、Molecular Templates, Inc.，振幅分别为104.84%、42.30%、39.99%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017220234ab6ad9bd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241017220234ab6ad9bd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","OXM","NRBO"],"gpt_icon":0},{"id":"2475299047","title":"Neurobo Pharmaceuticals, Inc.盘中异动 早盘急速上涨5.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475299047","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475299047?lang=zh_cn&edition=full","pubTime":"2024-10-16 21:49","pubTimestamp":1729086565,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日21时49分，Neurobo Pharmaceuticals, Inc.股票出现异动，股价急速拉升5.19%。Neurobo Pharmaceuticals, Inc.股票所在的生物技术行业中，整体跌幅为1.09%。Neurobo Pharmaceuticals, Inc.公司简介：NeuroBo Pharmaceuticals Inc 是一家临床阶段生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新型药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016214925971a0a27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241016214925971a0a27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4202","OXM","NRBO"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.neurobopharma.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":-0.0367},{"period":"3month","weight":-0.2602},{"period":"6month","weight":-0.4187},{"period":"1year","weight":-0.2625},{"period":"ytd","weight":-0.3616}],"compareEarnings":[{"period":"1week","weight":-0.0302},{"period":"1month","weight":-0.0071},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.0764},{"period":"1year","weight":0.2517},{"period":"ytd","weight":0.2331}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NeuroBo Pharmaceuticals, Inc.于2008年11月10日在密歇根以Michigan Life Therapeutics, LLC (MLT)这个名字注册成立。NeuroBo Pharmaceuticals, Inc.是一家临床阶段的生物技术公司，主要致力于开发和商业化治疗心脏代谢疾病的新药物。NeuroBo有两个主要项目，重点治疗非酒精性脂肪性肝炎（NASH）、肥胖症和2型糖尿病（T2D）。","yearOnYearQuotes":[{"month":1,"riseRate":0.625,"avgChangeRate":0.101843},{"month":2,"riseRate":0.375,"avgChangeRate":0.080599},{"month":3,"riseRate":0.5,"avgChangeRate":-0.020088},{"month":4,"riseRate":0.375,"avgChangeRate":-0.098642},{"month":5,"riseRate":0.25,"avgChangeRate":-0.104755},{"month":6,"riseRate":0.625,"avgChangeRate":0.103229},{"month":7,"riseRate":0.25,"avgChangeRate":-0.022415},{"month":8,"riseRate":0.125,"avgChangeRate":-0.219737},{"month":9,"riseRate":0.333333,"avgChangeRate":0.019058},{"month":10,"riseRate":0.111111,"avgChangeRate":-0.212992},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.109043},{"month":12,"riseRate":0.125,"avgChangeRate":-0.172588}],"exchange":"NASDAQ","name":"NeuroBo Pharmaceuticals, Inc.","nameEN":"NeuroBo Pharmaceuticals, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"NeuroBo Pharmaceuticals, Inc.,NRBO,NeuroBo Pharmaceuticals, Inc.股票,NeuroBo Pharmaceuticals, Inc.股票老虎,NeuroBo Pharmaceuticals, Inc.股票老虎国际,NeuroBo Pharmaceuticals, Inc.行情,NeuroBo Pharmaceuticals, Inc.股票行情,NeuroBo Pharmaceuticals, Inc.股价,NeuroBo Pharmaceuticals, Inc.股市,NeuroBo Pharmaceuticals, Inc.股票价格,NeuroBo Pharmaceuticals, Inc.股票交易,NeuroBo Pharmaceuticals, Inc.股票购买,NeuroBo Pharmaceuticals, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"NeuroBo Pharmaceuticals, Inc.(NRBO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供NeuroBo Pharmaceuticals, Inc.(NRBO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}